AnesthesiaNCT06945341
International Focus Group Discussion on Neuromuscular Monitoring.
An observational study of Anesthesia and Neuromuscular Blockade, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.
Trial summary
Focus-Group based discussion designed to gain more in-depth information on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Anesthesia, Neuromuscular Blockade, Neuromuscular Block, Residual
- What is being tested?
- Focus-Group discussion
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 16 participants
- Where
- 1 siteBelgium
- Study dates
- 1 Jul 2025to 30 Apr 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Active EU Anaesthesiologists
Active EU Anaesthesiologists
Trial locations and contacts
1 site in 1 country.
About this study
Official title: International Focus Group-based Discussion on Factors Facilitating an Increased Adoption of Neuromuscular Monitoring.
Focus-Group based discussion designed to gain more in-depth information on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts.
- Conditions
- Anesthesia, Neuromuscular Blockade, Neuromuscular Block, Residual, Perioperative/Postoperative Complications, Anaesthesiology Devices Associated With Adverse Incidents, Diagnostic and Monitoring Devices
- Being tested
- Focus-Group discussion
- Medical subject headings
- Delayed Emergence from Anesthesia, Postoperative Complications, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Focus-Group discussionBehavioural
Focus-Group discussion on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts.
| Study group | Role | What they receive |
|---|---|---|
| Group 1 Central and Eastern Europe | Central and Eastern Europe Receives: Behavioral: Focus-Group discussion | |
| Group 2 Northern Europe | Northern Europe Receives: Behavioral: Focus-Group discussion | |
| Group 3 Southern Europe | Southern Europe Receives: Behavioral: Focus-Group discussion | |
| Group 4 Western Europe | Western Europe Receives: Behavioral: Focus-Group discussion |
What is being measured
The primary outcome is the main question the study is designed to answer.
Thematic analysis
Thematic analysis of factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts
Measured: 90 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2025
- Study start1 Jul 2025
- Primary completion31 Dec 2025
- Study completion30 Apr 2026 (estimated)
Why it stopped: Suspended
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnesthesiaStudies of the same condition, open and under way.
- More trials run by Universitair Ziekenhuis BrusselThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 16 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Sponsor type
- University, hospital or other
- Collaborators
- AZ Sint-Jan AV
- Responsible party
- Principal investigator, Hugo Carvalho, AZ Sint-Jan AV
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06945341
- Sponsor's protocol ID
- FGNMM
- Status last verified
- Apr 2026
- First submitted
- 18 Apr 2025
- Last updated
- 4 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Focus-Group thematic analysis
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- International Focus Group-based Discussion on Factors Facilitating an Increased Adoption of Neuromuscular Monitoring.
- ClinicalTrials.gov ID
- NCT06945341
- Acronym / sponsor ID
- FGNMM
- Conditions
- Anesthesia, Neuromuscular Blockade, Neuromuscular Block, Residual, Perioperative/Postoperative Complications, Anaesthesiology Devices Associated With Adverse Incidents, Diagnostic and Monitoring Devices
- Study type
- Observational
- Recruitment status
- SuspendedReason stopped: Suspended
- Enrolment
- 16 participants (estimated)
- Lead sponsor
- Universitair Ziekenhuis BrusselUniversity, hospital or other
- Collaborators
- AZ Sint-Jan AV
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 30 Apr 2026 (estimated)
- First posted
- 25 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Focus-Group based discussion designed to gain more in-depth information on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Group 1 Central and Eastern Europe | – | Behavioral: Focus-Group discussionCentral and Eastern Europe |
| Group 2 Northern Europe | – | Behavioral: Focus-Group discussionNorthern Europe |
| Group 3 Southern Europe | – | Behavioral: Focus-Group discussionSouthern Europe |
| Group 4 Western Europe | – | Behavioral: Focus-Group discussionWestern Europe |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Active EU Anaesthesiologists
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Focus-Group discussionFocus-Group discussion on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts. | Behavioural | Group 1 Central and Eastern Europe, Group 2 Northern Europe, Group 3 Southern Europe, Group 4 Western Europe |
Primary outcome
Thematic analysis
Time frame: 90 minutes
Thematic analysis of factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2026.
- Individual participant dataSharing planned: Yes. Focus-Group thematic analysis
Related trials for Anesthesia
Not yet recruitingObservational study
"Comparison of Oxygen Reserve Index (ORI), End-Tidal Oxygen, and Time-Based Preoxygenation Targets With Arterial Blood Gas During Preoxygenation
Preoxygenation Adequacy Assessed by Oxygen Reserve Index, End-tidal Oxygen and Arterial Blood Gas
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
Not yet recruiting
A Randomized Controlled SaCo-VLM Trial
General Anaesthesia Using Supraglotic Airway
Not yet recruiting
Bispectral Index-Guided Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography
Deep Sedation, Endoscopic Retrograde Cholangiopancreatography
RecruitingPhase 4
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anesthesia and Neuromuscular Blockade, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Thematic analysis (time frame: 90 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.